Ignite Creation Date:
2025-12-24 @ 4:09 PM
Ignite Modification Date:
2026-03-29 @ 9:35 AM
Study NCT ID:
NCT02281266
Status:
UNKNOWN
Last Update Posted:
2014-11-21
First Post:
2014-10-15
Is Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Thymalfasin Adjuvant Therapy in Hepatitis B Virus (HBV)-Related Hepatocellular Carcinoma (HCC) After Curative Resection
Sponsor:
Jia Fan
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2015-01
Start Date Type:
None
Primary Completion Date:
2018-06
Primary Completion Date Type:
ESTIMATED
Completion Date:
2018-10
Completion Date Type:
ESTIMATED
First Submit Date:
2014-10-15
First Submit QC Date:
None
Study First Post Date:
2014-11-03
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2014-11-20
Last Update Post Date:
2014-11-21
Last Update Post Date Type:
ESTIMATED